Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Use this AKBA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AKBA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AKBA SEC filings page. Lician reads the product cache first so this HTML stays unique to Akebia Ther even when a live quote feed is slow.
Latest cached year on this hub. Full AKBA income, balance, and cash tables.